Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Postural deviations in individuals with chronic obstructive pulmonary disease (COPD)
2018
-
Early response to benralizumab in Canadian patients with severe eosinophilic asthma: Interim results from a prospective observational cohort.
8:99-107.
2024
-
Rapid access rehabilitation after exacerbations of chronic obstructive pulmonary disease: A Delphi study.
8:32-41.
2024
-
Barriers to multisite research in Canada: Experiences from a minimal risk COVID-19 study.
8:1-4.
2024
-
Maximum exercise capacity: Barcroft revisited in a large population.
8:260-269.
2024
-
Pulmonary rehabilitation and loneliness in individuals with chronic obstructive pulmonary disease (COPD).
8:245-253.
2024
-
Virtual pulmonary rehabilitation in Canada: A national survey of programs during the COVID-19 pandemic.
ahead-of-print:1-11.
2024
-
Triple inhaled therapy for asthma in Canada.
7:250-257.
2023
-
Management of cough in Canadian primary care and specialty practices: A survey of current knowledge of clinicians and allied health professionals.
7:124-132.
2023
-
The Role of Canadian respiratory therapists in adult critical care (ICURT-CAN): A scoping review.
7:158-170.
2023
-
2023 Canadian Respiratory Conference Abstracts.
7:1-52.
2023
-
Validity and reliability of the University of California and Los Angeles Loneliness Scale in individuals with chronic obstructive pulmonary disease.
7:70-78.
2023
-
Wearable device for sedentary behavior change in chronic obstructive pulmonary disease is feasible and acceptable.
7:79-85.
2023
-
Autoimmune pulmonary alveolar proteinosis in an adolescent girl with rapidly progressive dyspnea.
7:36-40.
2023
-
Multiple lung nodules, eosinophilia and severe asthma.
6:319-322.
2022
-
Ventilation and perfusion abnormalities following recovery from noncritical COVID-19.
6:304-313.
2022
-
Air Quality Health Index in primary care: A feasibility study.
6:248-255.
2022
-
Assessing the content validity of the Physical Therapy Competence Assessment for Airway Suctioning (PT-CAAS) in chronic and community care settings.
6:102-109.
2022
-
Heterogeneous manifestation of pulmonary ossification in idiopathic pulmonary fibrosis.
6:121-125.
2022
-
Pneumorrhachis due to invasive mucormycosis in a renal transplant recipient.
6:126-129.
2022
-
Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation.
6:9-13.
2022
-
Clinical relevance of sputum bronchial epithelial cells: A retrospective cross-sectional study.
6:35-40.
2022
-
In memoriam of Dr. Mark FitzGerald, MD, MB, FCCP, FRCPI, FRCPC.
6:4-5.
2022
-
Novel folliculin gene mutation and an elevated serum vascular endothelial growth factor-D level in the context of cystic lung disease.
6:58-62.
2022
-
Chronic cough: Investigations, management, current and future treatments.
5:404-416.
2021
-
Pan-Canadian standards for severe asthma in electronic medical records.
5:391-399.
2021
-
Relationship between dietary patterns and asthma: A systematic review and meta-analysis.
5:362-373.
2021
-
Reflections of an outgoing CTS president.
5:129-131.
2021
-
Canadian Thoracic Society (CTS) response to the COVID-19 pandemic.
5:125-127.
2021
-
Interstitial lung disease.
5:93-96.
2021
-
Parkinson’s disease dystonia as a cause of respiratory distress and stridor.
5:69-71.
2021
-
President’s Message.
5:1-2.
2021
-
A huge thank you!.
4:211-213.
2020
-
Delivering pulmonary rehabilitation during the COVID-19 pandemic: A Canadian Thoracic Society position statement.
4:232-235.
2020
-
Optimizing care for patients with interstitial lung disease during the COVID-19 pandemic.
4:226-228.
2020
-
Position statement from the Canadian Thoracic Society (CTS) on clinical triage thresholds in respiratory disease patients in the event of a major surge during the COVID-19 pandemic.
4:214-225.
2020
-
Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society Position Statement.
4:147-155.
2020
-
Meeting the challenge.
4:145-146.
2020
-
Addressing therapeutic questions to help Canadian health care professionals optimize COPD management for their patients during the COVID-19 pandemic.
4:77-80.
2020
-
Paradigm shift in the management of mild asthma: Focus toward a patient centered approach.
4:55-60.
2020
-
Real-world patterns of pirfenidone use and safety in patients with idiopathic pulmonary fibrosis in Canada: Data from INSPIRATION PLUS.
4:25-30.
2020
-
Oscillating positive expiratory pressure (OPEP) device therapy in Canadian respiratory disease management: Review, care gaps and suggestion for use.
3:233-240.
2019
-
Incidence, impact and natural history ofKlebsiellaspecies infections in cystic fibrosis: A longitudinal single center study.
3:148-154.
2019
-
Optimizing sputum cell counts prior to bronchial thermoplasty: A preliminary report.
3:143-147.
2019
-
Update in the diagnostic approach to fibrotic interstitial lung disease.
3:155-159.
2019
-
Comprehensive management of fibrotic interstitial lung diseases: A Canadian Thoracic Society position statement.
2:234-243.
2018
-
Transbronchial lung cryobiopsy for ILD: Ready or not, here it comes?.
2:257-258.
2018
-
ARIA 2016 executive summary: Integrated care pathways for predictive, preventive and personalized medicine across the life cycle.
2:78-83.
2018
-
This is what asthma looks like: Review of new and emerging functional imaging methods and results.
2:27-40.
2018
-
Use of telemedicine in the assessment of patients referred for pulmonary rehabilitation.
2:4-8.
2018
-
Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement.
1:133-141.
2017
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)